Scientists have unveiled a cutting-edge CRISPR technology that impressively targets the additional chromosome responsible for Down syndrome. In a further leap forward, researchers are also exploring ways to rewire the immune system, enabling it to generate crucial antibodies that are typically challenging to manufacture through conventional approaches.